Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review

Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review

Many different types of cancer can be treated with immunotherapy drugs called immune checkpoint inhibitors (ICIs). These drugs have altered the landscape of cancer treatment options since they function by triggering a stronger immune response to malignancy. As expected, ICIs’ modification of immune...

Full description

Bibliographic Details
Main Authors: Walid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, Amjad Abu Salman, Ashraf Abu Jama, Sondos Shalata, Kais Halumi, Alexander Yakobson
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Medicina
Subjects:
myocarditis
cardiac toxicity
inhibitors
immune checkpoint inhibitors (ICIs)
immune-related adverse events (IRAE)
cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
Online Access:https://www.mdpi.com/1648-9144/59/11/1946

Internet

https://www.mdpi.com/1648-9144/59/11/1946

Similar Items